Orencia 250 mg powder for concentrate for solution for infusion
- Licence status
- Active substances
- Abatacept
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/07/389/1-3
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Product documents
Licence information
- ATC code
- L04AA Selective immunosuppressants, L04AA24 abatacept
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued